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1. Introduction
  Malaria is a common and severe infection caused by five 
species of the Plasmodium genus: Plasmodium falciparum 
(P. falciparum), Plasmodium vivax (P. vivax), Plasmodium 
ovale (P. ovale), Plasmodium malariae (P. malariae) 
and Plasmodium knowlesi (P. knowlesi). Infections with
P. falciparum are associated to highest mortality rates, and 
infections with P. vivax and P. oval have quiescent liver 
stages that can lead to subsequent relapses. P. knowlesi is a 
species of malaria which is more and more reported in Asia 
South East and is distinguished by the fact that primates are 
the reservoir[1,2]. All kinds of malaria are transmitted by the 
bites of female anopheles mosquitoes infected. It is rare that 
the transmission is via blood[3], by exchanging contaminated 
needles or vertically from mother to fetus[4]. According to 
the World Health Organization[5], 3.2 billion of people living 
in 107 countries and territories in 2005 were at a risk of 
malaria, which resulted in approximately 500 million cases 
and 1 to 3 million death[6]. Approximately 60% of cases of 
malaria occur in Africa, 40% in Asia and less than 5% in 
America. Particularly for malaria with P. falciparum, the 
estimated distribution by region is as follows: 74% in Africa, 
25% in Asia and 1% in America[5]. Considering the behavior 
of malaria vectors (usually active at night), the proper 
use of treated bed nets (ITNs) is a measure of essential 
individual protection of malaria control[7,8] and wearing 
clothes impregnated with insecticide (permethrin) should be 
considered[9]. The use of insecticide treated mosquito nets 
greatly increases the protection provided by the net[7,9]. In 
addition, the insecticide-treated nets for long duration of 
action are an option to consider[10]. Treated nets represent 
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the vector control tool most promising in the prevention 
of malaria in Africa south of sahara[9]. In this study, we 
are led to evaluate the contribution of poses screen pre-
impregnated installed at openings and eaves of dwellings 
in the reduction of malaria transmission in the commune of 
Aguégués in Bénin.
2. Materials and methods
           
2.1. Study site
  The commune of Aguégués is located at 6 km from the city 
of Porto-Novo, the administrative capital and 15 km from 
Cotonou, Benin’s economic capital. The municipality covers 
a surface area of 52 km2 with 26 650 inhabitants distributed 
in 21 villages. The habitat, traditional type is made of 
bamboo built on pilings with a tin roof or straw. The windows 
and doors of dwellings are small. 
2.2. Methods
  The study was conducted from May 2011 to September 2011, 
period of rains. The poses screen preimpregnated are made 
in the commune by dressmakers using preimpregnated 
Olyset Nets that we bought at the pharmacy. The study 
is transversal and has based on children from 6 months 
to 59 months living in the commune. 320 children from 
the previous study were randomly selected according the 
following criteria: (parasitaemia ≥ 2 500 trophozoites/毺L
and temperature ≥ 37.7 曟): 5%. The investigation of the 
residence of the children enumerated 70 rooms in 4 villages 
of the commune. We selected 4 control villages with 311 
children whose rooms did not receive the poses screen 
preimpregnated. Thus, we summarize the villages that 
received the poses screen preimpregnated in treated zone 
and untreated villages in control zone. The poses screen 
preimpregnated are installed in April, one month before the 
start of the study. 
2.2.1. Variables studied
  Plasmodic Index (IP) is expressed as a percentage of 
subjects with Plasmodium in their blood at any stage of 
development.
 Plasmodic Index is about the percentage of carriers of 
Plasmodium among the subjects examined.
 Gametocyte Index (IG) expresses the percentage of subjects 
whose slide reveals the presence of gametocytes.
 Parasitic Density (DP) is estimated from the asexual stages 
of P. falciparum (trophozoites). It is expressed in number of 
trophozoites of P. falciparum per microliter of blood.
 Fever: we took the threshold of 37.5 曟 axillary temperature, 
from which the child is considered a fever.
 Hemoglobin level is expressed in grams per deciliter (g/dL) 
of blood, which allows to appreciate the state of anemia.
 Anemia: The normal value of hemoglobin levels in children 
less than 6 years according to WHO[11] was set at 11 g/dL of 
blood.
 Anemia is moderate if hemoglobin level is between 7 and 11 
g/dL and severe if it drops below 7 g/dL) [12]. 
2.2.2. Laboratory tests
2.2.2.1. Parasitic research
  The thick drop is the technique used. It has the advantage 
of giving a greater concentration of parasites, which 
is indispensable when the parasitaemia is minimal. 
Sampling is done to the pulp of a finger, either at the ear or 
venipuncture in folds of the elbow. For staining slides, we 
used the 3% Giemsa for 45 min. The reading is made at the 
objective 100. The research on parasites and counting are 
done on thick drop and the identification of different species 
of plasmodium is done on the smear. Parasite density was 
determined in 100 microscopic fields, corresponding to 
0.25 毺L of blood. The number of parasites per microliter of 
blood or the parasite density is obtained by multiplying the 
number of parasites in 100 fields by 4.
2.2.2.2. Dosage of hemoglobin level
  We practiced the technique of direct reading of the 
absorbance of the eluates of blood at 550 nm which consists 
to collect capillary blood on filter paper.
2.2.3. Data analysis
  The software Statistica 6 was used to analyze the data. 
For children, we considered the identification number, 
location of residence, age, sex, auxiliary temperature, 
parasite species and the progressive stage, the parasite 
density and hemoglobin level. The comparison of results was 
made between control zone and treated zone because the 
poses screen were administered by zone. Within statistical 
analysis, we used Chi-square test (氈
2
) and P value for the 
comparison of categorical variables. The estimates risk 
of fever, the fraction of fever attributable to malaria, the 
sensitivity, the specificity were evaluate by the method of 
Smith et al[13]. We divided our sample into six age groups. 
Thus the following groups were used: 6-11, 12-17, 18-23, 
24-35, 36-47, 48-59 (in months).
3. Results 
3.1. Distribution of children by sex and age groups 
                                                                                        
  From a total of 631 children aged 6 to 59 months selected 
for the study, 320 were in the treated zone and 311 in the 
control zone. Table 1 summarizes the distribution of children 
by gender, control zone and treated zone.
Table 1
Distribution of children by sex in the control zone and in the treated 
zone.
Sex
Treated zone Control zone
Total
Number % Number %
Male 122   38.12 120   38.58 242
Female 198   61.88 191   61.42 398
Total 320 100.00 311 100.00 631
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Table 2
Distribution of children by age group according to the control zone 
and the treated zone.
Age
(months)
Treated zone Control zone
Total
Number % Number %
  6-11   50   15.62   50   16.07 100
12-17   58   18.12   50   16.07 108
18-23   42   13.12   35   11.25   77
24-35   56   17.50   48   15.43 104
36-47   51   15.93   70   22.50 121
48-59   63   19.68   58   18.54 121
Total 320 100.00 311 100.00 631
3.2. Impact of poses screen pre-impregnated (PSP) on 
parasitological parameters
3.2.1. Impact on plasmodic index, on prevalence of
P. falciparum
  The impact of the intervention on plasmodic index (IP) 
in children aged 6 to 59 months in both zones is shown in
Table 3. Whether it’s in the treated zone or not, the IP is 
higher in Avagbodji’s villages than in villages of Houédomè 
and Zoungamè. The global IP was lower in villages where the 
PSP have been installed compared to unprotected villages 
(16.62% vs. 72.20%). The analysis of Table 3 clarifies that 
the global IP is more than 4 times lower in the treated zone 
than in the control zone among children (氈
2 = 81.39; P<10-6) 
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Figure 1. Global plasmodial prevalence of treated zone and control 
zone.
  The plasmodial prevalence in both zones is low in the 
age groups (6-11) and (12-17) but too high in the control 
zone. The prevalence is high in the age group (18-23) 
and stabilizes from the age group (36-47). Moreover, the 
prevalence is generally low in the treated zone than in the 
control zone (Figure 2).
Table 3
Global plasmodic index per village in the control zone and in the treated zone among children aged 6 to 59 months.
Treated zone Control zone
Villages Positifs (examined) IP Villages Positifs (examined) IP
Djèkpé 13 (93) 13.97% Gbodjè 50 (63) 79.36%
Akpadon 20 (84) 23.80% Bèmbè 1 62 (82) 75.60%
Agbodjèdo 10 (76) 13.15% Akodji 56 (81) 69.13%
Donoukpa   7 (67) 10.44% Trankomè 55 (85) 64.70%
Total 50 (320) 16.62% Total 223 (311) 72.20%
X2 = 81.39; P<10-6.
Table 4
Parasites Density in each village of the control zone and the treated zone among children aged 6 to 59 months.
DP
Control zone Treated zone
villages M.G. villages M.G.
Djèkpé 700 Gbodjè 328
Akpadon 764 Bèmbè 1 448
Agbodjèdo 441 Akodji 221
Donoukpa 495 Trankomè 239
M.G.T 600 M.G.T 309
X2 = 0.86; P= 0.35; M.G. = Geometric Mean; M.G.T. = Total Geometric Mean.
Table 5
Arithmetic mean of hemoglobin level in the control zone and in the treated zone among children aged 6 to 59 months.
Villages
Control zone Treated zone
Examined THb (IC à 95%) Villages Examined THb (IC à 95%)
Djèkpé   77 8.8 (8.5-9.2) Gbodjè   78 9.4 (9.0-9.8)
Akpadon   78 8.8 (8.5-9.2) Bèmbè 1   81 9.8 (9.5-10.2)
Agbodjèdo   79 8.6 (8.2-9.) Akodji   79 9.6 (9.2-10.0)
Donoukpa   77 8.6 (8.3-8.9) Trankomè   82 9.3 (8.8-9.8)
Total 311 8.7 Total 320 9.5
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Figure 2. Plasmodial prevalence according to age groups in the 
control zone and in the treated   zone.
3.2.2. Impact of PSP on gametocyte index to P. falciparum
  Concerning the impact of PSP on this parameter, the 
zone analysis shows that the gametocyte index did not 
differ significantly between the treated zone and control 
zone (27.8% vs. 29.1%, 氈
2 = 1.6, P = 0.18). P. falciparum 
gametocytes have been encountered with a frequency of 
35.67% for all zones (225 of 631 blades).
3.2.3. Impact of PSP on parasite density (DP)
  The impact of PSP on DP, was deeply affected in all villages 
of the treated zone where we note, as shown in Table 4, the 
DP was two times lower in villages of treated zone than in 
the control villages (309 vs. 600 trophozoites of P. falciparum 
(tf/毺L of blood).
3.2.4. Impact of PSP on the prevalence of DP  5 000 tf/毺L 
of blood
  Overall, 239 (37.8%) of 631 children had a parasitemia 
higher than or equal to 5 000 tf/毺L. The mean frequencies 
per zone were higher in the control zone, with a prevalence 
of 58.4% against 17.2% in the treated zone.
3.3. Impact of PSP on hemoglobin level (THb) and on 
prevalence of anemia
3.3.1. Impact of PSP on THb
  The  PSP has contributed to the significant increase THb 
in children living in the treated zone (9.5 g/dL) compared to 
children in the control zone (8.7 g/dL). The distribution of 
THb average values by zone is represented in Table 5 which 
indicates that they are greater than 9 g/dL in the treated zone 
while they are less than 9 g/dL in the control zone.
  Age is a variable positively influencing the THb and Figure 
3 clarifies that, whatever the treatment, the THb increases 
in children over 17 months. About the impact of PSP on THb 
based on age groups, a significant effect was observed in 
children over 24 months, among whom are noted THb higher 
in the treated area (9.8 g/dL) compared to the control zone 
(9.0 g/dL; 氈
2 = 5.4, P=0.001).
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Figure 3. Haemoglobin level according to age.
3.3.2. Prevalence of anemia
  The prevalence of anemia (moderate and severe) was not 
significantly different between the treated zone and control 
zone. However, we noted a prevalence of anemia in the 
control zone compared to the treated zone (Table 6). 
  Considering the median of THb in the study population 
(9.2 g/dL), with 80% of the population ranges from 7.6 g/dL 
and 10.6 g/dL, we realize that practically all children are 
included among the moderate anemia (92% in control zone 
and 87% in the treated zone). By against, severe anemias 
were rare in our sample and, although they presented 
a significant difference 27% between the treated area 
(5.1%) and control area (6.9%), we could not demonstrate 
a difference significant. However, although few in our 
sample, children with mild hemoglobin (THb≥11 g/dL) were 
relatively more frequent in the treated zone (10%) than in the 
control zone (1.9%, 氈
2 = 2.8, P=0.0009).
Table 6
Crude prevalence of anemia according to the treatment groups among 
children aged 6-59 months.
Zones
Prevalence (positifs/examined)
Mild hemoglobin moderate anemia severe anemia
Control zone   6/311 287/311 22/311
Treated zone 32/320 279/320 16/320
3.4. Impact of the PSP on the prevalence of fevers
  By comparing the prevalences of fever, we observe a 
difference between the control region (150 children on 
311, 48.23%) and treated area (56 on 320, 17.5%). (氈
2 = 
33.80; P=10-4). The risk of fever was significantly higher 
in children whose DP equalized or exceeded the value of 
5 000 tf/毺L, compared to uninfected children. According 
to our calculations, it is from this level that the proportion 
of fevers attributable to malaria becomes appreciable. We 
found so interesting to measure the impact of PSP on cases 
of fever associated with this level of parasitemia. Against all 
expectation, considering the impact of PSP on DP 5 000≥ 
tf/毺L, the prevalence of fever cases with DP≥5 000 tf/毺L
remained very similar between the two treatment groups 
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(7.5% for control zone and 6.9% treated zone ; 氈
2 = 0.26, P = 
0.80).
4. Discussion
  In Sub Saharan Africa, malaria is a leading cause of 
morbidity and mortality in children[14]. However, malaria 
infection itself is usually asymptomatic. This justifies the 
fact that the plasmodic index of the study was 72.20% in the 
control zone, while severe anemia in this area was 6.9%. One 
transversal study to determine the plasmodic index in an 
area, gave over 50% of school children, have positive thick 
smears without any associated symptoms[15,16]; parasite 
densities are then usually low. Among non immune patients 
that are infants, and in the case of P. falciparum only, 
the clinical condition can quickly deteriorate to evolve to 
severe anemia. In areas of stable malaria, the child will 
gradually acquire a protective immunity that can protect 
him against severe manifestations of malaria. The PSP 
has therefore performed a decisive impact in reducing 
anemia in the treated zone. In tropical Africa the gene for 
hemoglobin S (HbS) confers protection against malaria. The 
high frequency of this gene in sub-Saharan populations 
could result from a balance between on the one hand 
early mortality that drive the clinical manifestations of 
sickle cell anemia patients homozygote (SS) and, secondly, 
about the protection of uncomplicated and severe malaria, 
60% and 90%[17] conferred by the gene heterozygotes (AS). 
This protection, which is a slower growth of the parasite 
in red blood cells containing HbS, is not complete and is 
expressed mainly in young children[18]. This could confirm 
the low prevalences in the two study zones among children 
of both age groups[6-11] and[12-17]. Hill’s work in 1991 
showed that the presence of HLA-Bw 53, frequently found 
in West Africa, caused a 40% decrease in the number of 
neuropaludismes and severe anemia[19]. The protection 
associated with major histocompatibility complex would be 
explained by an increase in the humoral response and the 
stimulation of cytotoxic T lymphocytes acting against the 
intrahépatocytaire stage of the parasite[20]. McGuire et al., 
in 1994, revealed the protective role of the developer gene 
of TNF against malaria pernicious attacks[21]. All children 
have an inborn protective factor of physiological origin. 
Indeed, the HbF inhibits the growth of P. falciparum in red 
blood cells[22]. This would explain, in part, the low parasite 
densities encountered during infections in young children 
in the study. This protection disappears gradually with 
the replacement of HbF by hemoglobin A. Hence the rise 
in prevalence in both studies zone from the age group[18-
23]. Other factors related to the lifestyle of the child will 
have a role in the occurrence of malaria infections. Breast 
feeding, usually exclusive in Africa during the first months 
of life protects children. Indeed, the absence of para-
aminobenzoic acid (PABA) in breast milk, limit parasite 
development that needs for the synthesis of its DNA[23]. In 
stable endemic zone, a large proportion of children with 
parasites are asymptomatic. The use of new methods such 
as PCR, including the detection threshold is lower than 
the thick film which is the gold standard, shows that the 
number of asymptomatic children is still underestimated[24]. 
In these areas where subjects gradually develop acquired 
immunity, the mere presence of parasites in the blood of a 
subject does not diagnose malaria. Thus, in one study, only 
45% of subjects consulting for fever which had been made 
the diagnosis of malaria attacks indeed suffer from this 
disease[25]. Hence the need for determining the detection 
threshold. Several teams have calculated thresholds[16,26,27]. 
However, the confidence interval of these thresholds is 
wide and its choice will depend on the sensitivity and 
specificity desired. Rooth and Bjorkman, for the diagnosis 
of malaria, recommends a threshold of 400 parasites/毺L for 
children older than one year, for a sensitivity of 96%, and no 
threshold for children younger than one year[28]. In a study 
conducted of children aged under 6 years in highly endemic 
area, Smith et al. find, for a threshold of 5 000 parasites/毺L,
sensitivity and specificity of 80%[16]. The pyrogenic threshold 
of parasitaemia is a good tool for epidemiological assessment 
but difficult to use in the interests of clinical diagnosis[29]. 
Different clinical algorithms have been proposed to refine the 
diagnosis of malaria as the duration and intensity of fever[30] 
or absence of cough, spleen size, presence of fever, vomiting, 
stool normal, the absence of pulmonary symptoms[31]. 
All bring improvements in terms of specificity for loss of 
sensitivity. However, many observations can be made, 
concerning in particular on the experimental conditions 
for the assessment of these algorithms. These misgivings 
are shared by Petersen et al who report observations of a 
subgroup of children who had lower body temperatures 
despite high parasite densities and suggest that this clinical 
condition could be an indicator of the occurrence of severe 
malaria among children[32]. Only 1% to 2% of children with 
malaria will develop a severe attack. The peak incidence of 
cerebral malaria in area of holo and hyperendemic malaria 
occurs around 45 months while severe anemia occur earlier 
to 28 months[33]. This explains the prevalence of our study 
which amount to 74% in age groups[24-35] and[48-59]. With 
PSP, the prevalences are reduced to 10% in age group[24-
35] and 20% in age group[48-59]. Multiple hypotheses have 
been advanced to explain the causes of a shift to a severe 
attack[34]. The initial inoculum, possibly caused by several 
anopheles bites, could shorten the time to onset of heavy 
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parasitemia, time becomes too short to allow the child to 
develop an appropriate immune response and sufficient to 
control the multiplication of parasites. This would explain 
the effectiveness of treated nets which, without allowing a 
significant reduction in morbidity, would have an impact on 
mortality[35]. The virulence of strains, which may be variable, 
may also be mentioned[36]. This virulence may be expressed 
through the ability of the strain to secrete TNF by the cells. 
The latter is involved in the physiopathology of cerebral 
malaria. Mendis and Carter suggest the hypothesis that 
sensitization to the parasite may predispose the individual 
to the occurrence of a severe attack[37-46]. The production of 
interferon by activated potentiate cells enabling monocytes 
to produce TNF. Drug resistance strains could also affect 
the risk of progression to severe malaria. The child often 
happens, with or without treatment, to control malaria 
attacks occurring. However, these recurrent infections 
are not without consequences on the overall health and 
ability to fight against various diseases and environmental 
stresses to which children are subjected. Children anemias 
in Africa have two main sources: a nutritional origin with 
microcytic anemia caused by iron deficiency and anemia 
macrocytic caused by vitamin B12 or folate[47] and with 
intestinal parasitoses and malaria[48,49]. The prevalence of 
anemia varies according to study areas but is generally high. 
They can affect more than half of children such as Tanzania, 
where Premji et al report a prevalence of 74% in children 
younger than 3 years[50]. By protecting for one year a group 
of children using ITNs, Shiff et al noted a reduction by half 
of the prevalence of anemia compared to a group of control 
children[51]. Despite the increase in malaria prevalence 
and parasite densities from the age of four months[52], the 
prevalence of anemia decreased with age[51] suggesting 
that the risk factors of occurrence of anemia have changed 
and/or the child has a better capacity for regeneration of 
destroyed red blood cells[53]. This explains the gradual rise 
in hemoglobin in both study areas with increased rates of 
the treated area.
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